Thyroid disease

Levothyroxine Treatment in Pregnant Women with Thyrotropin Levels Ranging Between 2.5 and 10 mIU/L: A Propensity Score Matched Analysis

ThyroidPublished Retrospective cohort study

Authors' conclusion

LT4 treatment was significantly associated with a lower risk of pregnancy loss and a higher risk of small-for-gestational-age infants in pregnant women with TSH levels of 2.5-10 mIU/L. An increased risk of preterm birth was observed in the LT4-treated group among TPOAb-positive participants with TSH levels of 2.5-4.0 mIU/L.

Study context

Population
Chinese pregnant women with first-trimester TSH 2.5–10 mIU/L and normal free thyroxine (11.8–18.4 pmol/L)
Participants
4,370 women668 matched pairs
Exposure
Levothyroxine (LT4) treatment vs no LT4 treatment
Outcome
Adverse pregnancy outcomes:
  • Pregnancy loss
  • Small-for-gestational-age infants
  • Preterm birth
  • Other complications
Follow-up
Completion of pregnancy
Methodological detailspropensity-score matched, 1:1 nearest-neighbor matching
  • Propensity-score matched
  • 1:1 nearest-neighbor matching

Main finding

As reported in the abstract

Adverse pregnancy outcomes (propensity score matching (PSM) cohort)
LT4-treated vs UntreatedRelative risk (95% CI)
Pregnancy loss; decreased risk with LT4
0.528(0.344–0.812)
SGA infants; increased risk with LT4
1.595(1.023–2.485)

Observational data: associations, not effects.

Further findings

OutcomeRR (95% CI)
Preterm birth, TPOAb-positive with high-normal TSH (2.5-4.0 mIU/L)LT4-treatedvs UntreatedIncreased risk with LT42.214 (1.016–4.825)

Subgroups by thyroid peroxidase antibody (TPOAb) status and TSH level

Effects of LT4 on pregnancy loss and SGA mainly from TPOAb-negative participants

Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.

Original publication

Levothyroxine Treatment in Pregnant Women with Thyrotropin Levels Ranging Between 2.5 and 10 mIU/L: A Propensity Score Matched Analysis. Thyroid. Published 9 May 2024. doi:10.1089/thy.2023.0662

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.